The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 4538 -4546
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803989

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lohmann, C.
Right arrow Articles by Häcker, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lohmann, C.
Right arrow Articles by Häcker, G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Melanoma

Induction of Tumor Cell Apoptosis or Necrosis by Conditional Expression of Cell Death Proteins: Analysis of Cell Death Pathways and In Vitro Immune Stimulatory Potential 1

Christine Lohmann2,*, Andreas Muschaweckh2,*, Susanne Kirschnek2,*, Luise Jennen{dagger}, Hermann Wagner* and Georg Häcker3,*

* Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany; and {dagger} Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

For the efficient stimulation of T cells by tumor Ag, tumor-derived material has to be presented by dendritic cells (DC). This very likely involves the uptake of dead tumor cells by DC. Cell death in tumors often occurs through apoptosis, but necrotic cell death may also be prevalent. This distinction is relevant because numerous studies have proposed that apoptotic cells have immunosuppressive effects while necrosis may be stimulatory. However, a system has been lacking that would allow the induction of apoptosis or necrosis without side effects by the death stimuli used experimentally. In this study, we present such a system and test its effects on immune cells in vitro. B16 mouse melanoma cells were generated and underwent cell death through the doxycycline-inducible induction of death proteins. In one cell line, the induction of BimS induced rapid apoptosis, in the other line the induction of the FADD death domain induced nonapoptotic/necrotic cell death. BimS-induced apoptosis was associated with the typical morphological and biochemical changes. FADD death domain induced necrosis occurred through a distinct pathway involving RIP1 and the loss of membrane integrity in the absence of apoptotic changes. Apoptotic and necrotic cells were taken up with comparable efficiency by DC. OVA expressed in cells dying by either apoptosis or necrosis was cross-presented to OT-1 T cells and induced their proliferation. These results argue that it is not the form of cell death but its circumstances that decide the question whether cell death leads to a productive T cell response.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Wilhelm Sander-Stiftung.

2 C.L., A.M., and S.K. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Georg Hacker, Technische Universitat Munchen, Trogerstrasse 30 D-81675, Munich, Germany. E-mail address: hacker{at}lrz.tu-muenchen.de

4 Abbreviations used in this paper: DC, dendritic cell; BMDC, bone marrow-derived DC; CM, coumermycin; FADD, Fas-associated death domain protein; FADD-DD, FADD death domain; PARP, poly(ADP-ribose) polymerase; PI, propidium iodide; PS, phosphatidylserine; tet, tetracycline.

5 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.